ProCyte Receives Patent on New Wound Care Dressing
REDMOND, Wash., Nov. 10 /PRNewswire/ -- ProCyte Corporation (OTC Bulletin
Board: PRCY - news), a leading skin
care and tissue repair company, announced today that it has received a patent on its
absorbent wound care dressings used for
capturing excess fluids secreted from wounds and holding it away from the tissue.
The newly patented dressings consist of beads or pads that absorb large quantities of fluid
and remove excess moisture from
wounds to maintain an optimal healing environment. The novel hydropolymer technology
can also deliver various antibiotic and
anti-fungal agents to wounds while absorbing fluid, thereby addressing other specific
wound conditions and medical needs.
A number of ProCyte's products contain the absorbent hydropolymer technology including
the Company's OsmoCyte® Pillow
Dressing, OsmoCyte® PCA Pillow Dressing and Osmocyte® Island Dressing.
The OsmoCyte® Island product was recently introduced for use in nursing homes and
home care situations as well as for
podiatric care. This dressing is designed to cushion wounds from further trauma while
preventing excess moisture from causing
additional wound and skin damage. ProCyte also plans to market the newly patented
dressing for use in cosmetic procedures
such as the rapidly growing liposuction market where abundant amounts of fluid can cause
serious problems.
Commenting on its new patent, ProCyte's President and CEO Jack Clifford stated, ''We
are extremely excited about the uses
for our new wound care dressings, which were developed to be cost-effective while
providing patients with an optimal level of
comfort. The company now has 19 issued US patents and over 130 issued foreign patents
and patent registrations related to its
copper-based technology and a variety of healthcare applications.''
In the past year, ProCyte has expanded its focus in the plastic surgery and dermatology
markets with a series of unique
products using its patented Copper Peptide complexes. These products include the
Complex Cu3(TM) System for use
following microdermabrasion and laser resurfacing; the Neova(TM) Therapy anti-aging
line including a night creme and eye
serum; Tricomin® Advanced Care for Thinning Hair products; and GraftCyte(TM)
products for use following hair transplant
surgery.
About ProCyte:
ProCyte Corporation is a Healthcare Products Company that develops, manufactures and
markets products for tissue repair,
wound care, skin health and hair care. ProCyte's product portfolio includes
comprehensive skin care lines for therapeutic care,
pigmentation concerns, anti-aging products and products for thinning hair. The Company's
products incorporate its patented
copper peptide technology and are marketed both directly and through distribution
partners.
This report may contain forward-looking statements and should be read in conjunction
with the Company's annual report of
Form 10-K and its quarterly reports on Form 10-Q. The Company's results may vary
significantly from quarter to quarter and
will depend, among other factors, on product launches and market acceptance,
manufacturing contracts, and distribution
agreements.
SOURCE: ProCyte Corporation
|
